Alpha 2.0
Login Register
» Authors » Desiree van der Heijde

Desiree van der Heijde

Explore the profile of Desiree van der Heijde including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 728
Citations 29839
Followers 0
Related Specialties
Rheumatology
General Medicine
Public Health
Top 10 Co-Authors
Robert Landewe
Maxime Dougados
Sofia Ramiro
Xenofon Baraliakos
Tore K Kvien
Walter P Maksymowych
Jurgen Braun
Joachim Sieper
Robert B M Landewe
Josef S Smolen
Published In
Ann Rheum Dis
J Rheumatol
Rheumatology (Oxford)
RMD Open
Arthritis Rheum
Affiliations
Soon will be listed here.
Recent Articles
11.
Remission versus low disease activity as treatment targets in rheumatoid arthritis: how to strike the right balance between too strict and too lenient targets? A meta-epidemiological study of individual patient data
Duarte C, Jacobs J, Ferreira R, Welsing P, Gossec L, Machado P, et al.
RMD Open . 2024 Nov; 10(4). PMID: 39516011
Objectives: To evaluate the impact of using Simplified Disease Activity Index (SDAI)-LDA (low disease activity) versus different definitions of remission as a treatment target in established rheumatoid arthritis. Methods: A...
12.
Baseline and 2-year differences in spinal symptoms and spinal and hip mobility in early axial spondyloarthritis and non-axial spondyloarthritis chronic back pain patients
Bento da Silva A, Ramiro S, van Lunteren M, Marques M, van de Sande M, Fongen C, et al.
RMD Open . 2024 Oct; 10(4). PMID: 39461873
Objective: To compare spinal symptoms and spinal/hip mobility at baseline and 2 years in early axial spondyloarthritis (axSpA) and non-axSpA chronic back pain (BP) patients. Methods: Baseline and 2 years...
13.
Prevalence and incidence of uveitis in patients with spondyloarthritis: the impact of the biologics era. Data from International ASAS-COMOSPA Study
Maldonado-Ficco H, Lopez-Medina C, Perez-Alamino R, Waimann C, Maldonado-Cocco J, Molto A, et al.
Rheumatology (Oxford) . 2024 Oct; PMID: 39361425
Objectives: Uveitis is a common extra-musculoskeletal manifestation in Spondyloarthritis (SpA). The aim of this study was to analyze the prevalence of uveitis in SpA patients, its association with geographical areas...
14.
Change in different classes of chronic back pain suspicious of axial spondyloarthritis: a latent transition analysis of the SPACE cohort
Bosch P, Sepriano A, Marques M, van der Heijde D, Landewe R, van Lunteren M, et al.
RMD Open . 2024 Sep; 10(3). PMID: 39349053
Objectives: To follow up four previously identified classes 'pure axial spondyloarthritis' (axSpA) ('axial'), 'axSpA with peripheral signs' ('inflammatory back pain+peripheral'), 'axSpA at risk' and 'no spondyloarthritis' ('no SpA'). They reflect...
15.
Agreement between patient-reported flares and clinically significant flare status in patients with rheumatoid arthritis in sustained remission: data from the ARCTIC REWIND trials
Holten K, Paulshus Sundlisaeter N, Sexton J, Kjorholt K, Nordberg L, Moholt E, et al.
RMD Open . 2024 Sep; 10(3. PMID: 39237295
Objectives: To explore the agreement between patient-reported flare status and clinically significant flare status in patients with rheumatoid arthritis (RA) in sustained remission. Method: Patients with RA in remission for...
16.
Do quality of life and work productivity change in early axial spondyloarthritis and non-axial spondyloarthritis patients after two years?
Bento da Silva A, Ramiro S, Boel A, van Lunteren M, Marques M, van de Sande M, et al.
Rheumatology (Oxford) . 2024 Jun; PMID: 38937277
Objective: To compare health-related quality of life (HRQoL) and work productivity in axial spondyloarthritis (axSpA) and non-axSpA patients with chronic back pain of < 2 years (2 y). Methods: Baseline...
17.
When Usual Care Is Not So Usual: Protocol Violations and Generalizability in a Treat-to-Target Strategy Trial in Patients With Axial Spondyloarthritis
Lopez-Medina C, Van den Bosch F, van der Heijde D, Dougados M, Molto A
Arthritis Care Res (Hoboken) . 2024 Jun; 76(11):1540-1548. PMID: 38924366
Objective: The objective of this study was to evaluate the impact of protocol violations in the treat-to-target group in the Tight Control in Spondyloarthritis (TICOSPA) trial and to compare the...
18.
Inflammation in the posterior elements, in particular the facet joint and facet joint ankylosis over 2-year follow-up in radiographic axial spondyloarthritis
de Hooge M, Stal R, Sepriano A, Baraliakos X, Reijnierse M, Braun J, et al.
RMD Open . 2024 Jun; 10(2). PMID: 38851237
Objectives: To assess the association of posterior element (PE) and facet joint (FJ) inflammation with subsequent new FJ ankylosis (FJA) on MRI, in patients with radiographic axial spondyloarthritis (r-axSpA). Methods:...
19.
Upadacitinib in Active Non-radiographic Axial Spondyloarthritis: 1-Year Data From a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial
Van den Bosch F, Deodhar A, Poddubnyy D, Maksymowych W, van der Heijde D, Kim T, et al.
ACR Open Rheumatol . 2024 May; 6(8):470-480. PMID: 38747163
Objective: Upadacitinib improved the signs and symptoms of non-radiographic axial spondyloarthritis (nr-axSpA) versus placebo over 14 weeks in the primary analysis of the SELECT-AXIS 2 nr-axSpA study. Here, we evaluated...
20.
Disease modification in axial spondyloarthritis - still a controversy?
de Hooge M, van der Heijde D
Curr Opin Rheumatol . 2024 May; 36(4):302-308. PMID: 38712691
Purpose Of Review: This review evaluates recent advancements in disease-modifying therapies for axial spondyloarthritis (axSpA). Recent Findings: A recent study could not demonstrate an additional effect of NSAID therapy on...